Le contrat de licence du payeur, ou « modèle Netflix », pour les thérapies contre le virus de l'hépatite C permet un accès universel au traitement, réduit les coûts et encourage l'innovation et la concurrence
Summary High unit prices of treatments limit access. For epidemics like that of hepatitis C virus (HCV), reduced treatment access increases prevalence and incidence, making the infectious disease increasingly difficult to manage. The objective of the current study was to construct and test an alternative pricing model, the Payer License Agreement (PLA), and determine whether […]
French 
English 
Spanish 
Russian 
Arabic